Universidad Panamericana School of Medicine, Mexico City, Mexico.
Universidad Panamericana School of Medicine, Mexico City, Mexico; Universidad Panamericana School of Nursing, Mexico City, Mexico.
Am J Kidney Dis. 2016 Mar;67(3):499-506. doi: 10.1053/j.ajkd.2015.08.033. Epub 2015 Dec 19.
The costs of health care place developing countries under enormous economic pressure. Latin America is a region characterized by wide ethnic and per capita gross domestic product variations among different countries. Chronic kidney failure prevalence and incidence, as well as provision of renal replacement therapy (RRT), have increased in all Latin American countries over the last 20 years. From an ethical point of view, life-sustaining therapies such as RRT should be available to all patients with chronic kidney disease who might benefit. However, even among Latin American countries with similar per capita incomes and health care expenditures, only some have been able to achieve universal access to RRT. This indicates that it is not just a problem of wealth or distribution of scarce health care resources, but one of social justice. Strategies to increase the availability of RRT and renal palliative-supportive care, as well as implementation of interventions to prevent chronic kidney disease development and progression, are needed in Latin America and other developing countries.
医疗保健成本使发展中国家面临巨大的经济压力。拉丁美洲是一个地区,其特点是不同国家之间存在广泛的种族和人均国内生产总值差异。在过去的 20 年中,所有拉丁美洲国家的慢性肾衰竭患病率和发病率以及肾脏替代疗法(RRT)的提供都有所增加。从伦理的角度来看,RRT 等维持生命的治疗方法应该提供给所有可能受益的慢性肾脏病患者。然而,即使在人均收入和医疗保健支出相似的拉丁美洲国家中,也只有一些国家能够实现 RRT 的普及。这表明,这不仅仅是财富或稀缺医疗资源分配的问题,而是社会正义的问题。拉丁美洲和其他发展中国家需要增加 RRT 和肾脏姑息支持性护理的可及性,并实施干预措施以预防慢性肾脏病的发生和进展。